HEALTHBLOOMBERG
Denmark to Study Whether Wegovy Can Get More People Working
Denmark is studying whether Wegovy can increase employment rates. The country was among the first to launch the drug in late 2022.
Related Signal
Adjacent reporting
- China steps up Alzheimer’s, Parkinson’s drug push, looks to TCM
- US Job Openings Jump to Highest Level in Almost Two Years
- Exclusive: Race begins to trial Ebola drugs amid current outbreak
- Akeso To Boost Manufacturing Of Cancer Drug
- Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
- GSK reports promising early results in ovarian and womb cancer drug trial